AKAP9 anticorps (N-Term)

N° du produit ABIN570727

Détail du produit anti-AKAP9 anticorps

Antigène: AKAP9 (A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9))

Épitope: N-Term

Reactivité: Humain

Hôte: Chèvre

Clonalité: Polyclonal

Conjugué: Cet anticorp AKAP9 est non-conjugé

Application: ELISA

Fonction: AKAP9 / YOTIAO

Séquence: QRKAQSDGQS PSKK

Specificité: This antibody is expected to recognize isoforms 2 and 3 (NP_005742.4, NP_671714.1)

Réactivité croisée: Chien, Humain

Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Classe de qualité: Recent

Immunogène: Peptide with sequence QRKAQSDGQSPSKK-C, from the N Terminus of the protein sequence according to NP_005742.4, NP_671714.1.

Isotype: IgG

Information d'application

Indications d'application:

Western Blot: Not yet tested - our routinely used western blotting protocol does not allow detection of proteins as large as the calculated size of 453 kDa according to NP_005742.4. Therefore we cannot recommend an optimal concentration and the antibody i

Peptide ELISA: antibody detection limit dilution 1:64000.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Minimize freezing and thawing.

Stock: -20 °C

Stockage commentaire: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Détails sur AKAP9

Antigène: AKAP9 (A Kinase (PRKA) Anchor Protein (Yotiao) 9 (AKAP9))

Autre désignation: AKAP9 (AKAP9 Produits)

Synonymes: anticorps AKAP-9, anticorps AKAP350, anticorps AKAP450, anticorps CG-NAP, anticorps HYPERION, anticorps LQT11, anticorps MU-RMS-40.16A, anticorps PPP1R45, anticorps PRKA9, anticorps YOTIAO, anticorps 5730481H23Rik, anticorps AW545847, anticorps C79026, anticorps mKIAA0803, anticorps Gisp, anticorps Yotiao, anticorps AKAP9, anticorps wu:fj02h02, anticorps prka9, anticorps yotiao, anticorps akap350, anticorps akap450, anticorps hyperion, anticorps AKAP120, anticorps A-kinase anchoring protein 9, anticorps A kinase (PRKA) anchor protein (yotiao) 9, anticorps A kinase (PRKA) anchor protein 9, anticorps A-kinase anchoring protein AKAP120, anticorps AKAP9, anticorps Akap9, anticorps akap9, anticorps CpipJ_CPIJ006715, anticorps CpipJ_CPIJ017436

Sujet: AKAP9, A kinase (PRKA) anchor protein (yotiao) 9, AKAP350, AKAP450, CG-NAP, HYPERION, KIAA0803, MU-RMS-40.16A, PRKA9, YOTIAO, A-kinase anchor protein 9, A-kinase anchor protein, 350 kDa, A-kinase anchoring protein 450, AKAP120-like protein, AKAP9-BRAF fusi

ID gène: 10142

NCBI Accession: NP_005742, NP_671714

Pathways: M Phase, SARS-CoV-2 Protein Interactome